Indivi: Valuation, Funding & Investors
Indivi is an ISO 13485 and ISO 27001-certified TechBio company headquartered in Basel (Switzerland) and developing future-proof functional biomarkers derived from DHT tools measuring key disability concepts of importance for drug development trials in neuroscience therapeutic areas, e.g. multiple sclerosis, Parkinson's disease and other alpha-synucleinopathies, Alzheimer's disease and related dementias, muscular dystrophies and neuromuscular disorders.
Leadership & Board
- Current Number of Employees
- 84
- Current LinkedIn Followers
- 5,999
Latest Estimated Valuation
- Total Amount Raised
- $15M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $15M
- Latest Funding Round
- Investment
Company Momentum Positive
Indivi LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
Indivi had 84 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Indivi had 5,999 followers as of October 26, 2026. The number of followers increased by 8 (0.13%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Nov 12, 2025 | Investment | $15.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Ava Investors | Investment |
Similar Companies
A snapshot of private companies similar to Indivi, helping you discover and navigate related company profiles.
Related News and Analysis
